TCS, HDFCBANK, SBI Liquid Fund (G)
Camlin Fine Sciences Ltd.
Camlin Fine Sciences
NSE
₹ 0.00
0.00 (0.00)%
Chemicals
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 28 05 2021 | Dividend & Audited Results |
| 13 08 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 07 02 2022 | Quarterly Results |
| 19 05 2022 | Audited Results |
| 12 08 2022 | Quarterly Results |
| 12 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 22 05 2023 | Audited Results |
| 11 08 2023 | Quarterly Results |
| 06 11 2023 | Quarterly Results |
| 09 02 2024 | Quarterly Results |
| 11 11 2024 | Quarterly Results |
| 22 11 2024 | Right Issue of Equity Shares & Inter alia to consider and approve (subject to regulatory/ statutory and other approvals, as may be required) the following: 1. The revision of the quantum of the proposed Rights Issue to an amount not exceeding Rs. 225 crores; and 2. Issue of any debt securities of the Company |
| 02 01 2025 | Inter alia, to consider, discuss and decide various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date and timing of the Rights Issue |
| 14 02 2025 | Quarterly Results |
News
No News data available
